IL-33 Is a Negative Regulator of Vaccine-Induced Antigen-Specific Cellular Immunity

J Immunol. 2019 Feb 15;202(4):1145-1152. doi: 10.4049/jimmunol.1800833. Epub 2019 Jan 14.

Abstract

The cytokine IL-33 is a well-established inducer of Th2 responses. However, roles for IL-33 in promoting CD8, Th1, and T regulatory cell responses have also emerged. In this study, the role of IL-33 as a regulator of particulate vaccine adjuvant-induced Ag-specific cellular immunity was investigated. We found that polymeric nanoparticles surpassed alum in their ability to enhance Ag-specific CD8 and Th1 responses. IL-33 was a potent negative regulator of both CD8+ T cell and Th1 responses following i.m. vaccination with Ag and nanoparticles, whereas the cytokine was required for the nanoparticle enhancement in Ag-specific IL-10. In contrast to the effect on cellular immunity, Ab responses were comparable between vaccinated wild-type and IL-33-deficient mice. IL-33 did not compromise alum-induced adaptive cellular immunity after i.m. vaccination. These data suggest that IL-33 attenuates the induction of cellular immune responses by nanoparticulate adjuvants and should be considered in the rational design of vaccines targeting enhanced CD8 and Th1 responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens / administration & dosage
  • Antigens / immunology*
  • Immunity, Cellular / immunology*
  • Injections, Intramuscular
  • Interleukin-33 / deficiency
  • Interleukin-33 / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry
  • Vaccination
  • Vaccines / administration & dosage
  • Vaccines / immunology*

Substances

  • Antigens
  • Il33 protein, mouse
  • Interleukin-33
  • Vaccines